

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.77118885 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.68859875 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.11807941 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.01764735 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.01764735 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.62876290 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 6.62876290 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.29379374 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19668662 |
| 10 | drug metabolic process (GO:0017144) | 6.01314832 |
| 11 | oxidative demethylation (GO:0070989) | 5.70623566 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.66635379 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.66635379 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.66635379 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65757571 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.57311453 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.38160505 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.33350208 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.31084425 |
| 20 | urea metabolic process (GO:0019627) | 5.19175130 |
| 21 | urea cycle (GO:0000050) | 5.19175130 |
| 22 | glyoxylate metabolic process (GO:0046487) | 5.15219334 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.05825534 |
| 24 | phenylpropanoid metabolic process (GO:0009698) | 4.97234068 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.94461662 |
| 26 | protein carboxylation (GO:0018214) | 4.91401293 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.91401293 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.90216292 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.88407931 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.88230184 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.87552229 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.87213084 |
| 33 | bile acid metabolic process (GO:0008206) | 4.86236891 |
| 34 | alkaloid metabolic process (GO:0009820) | 4.86140241 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.80418423 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80248149 |
| 37 | cysteine metabolic process (GO:0006534) | 4.80141744 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 4.77120608 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.70878541 |
| 40 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.66013492 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.63500290 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.63500290 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.63500290 |
| 44 | phospholipid efflux (GO:0033700) | 4.60113604 |
| 45 | regulation of complement activation (GO:0030449) | 4.57993569 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.53831012 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.50295916 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.45183405 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.45183405 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.41997029 |
| 51 | cholesterol efflux (GO:0033344) | 4.29346805 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.29190307 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.28647366 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.28469316 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.27399873 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.24481065 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.24481065 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.20244634 |
| 59 | low-density lipoprotein particle remodeling (GO:0034374) | 4.11765618 |
| 60 | amine catabolic process (GO:0009310) | 4.09641497 |
| 61 | cellular biogenic amine catabolic process (GO:0042402) | 4.09641497 |
| 62 | cellular glucuronidation (GO:0052695) | 4.05881610 |
| 63 | ethanol metabolic process (GO:0006067) | 4.04221666 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.02938161 |
| 65 | plasma lipoprotein particle assembly (GO:0034377) | 4.02183300 |
| 66 | cellular ketone body metabolic process (GO:0046950) | 4.01747687 |
| 67 | cellular amino acid catabolic process (GO:0009063) | 3.95436955 |
| 68 | lysine metabolic process (GO:0006553) | 3.92840155 |
| 69 | lysine catabolic process (GO:0006554) | 3.92840155 |
| 70 | ethanol oxidation (GO:0006069) | 3.92247414 |
| 71 | regulation of acrosome reaction (GO:0060046) | 3.91820053 |
| 72 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.89222495 |
| 73 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.88464122 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 3.86966185 |
| 75 | drug catabolic process (GO:0042737) | 3.83914266 |
| 76 | negative regulation of lipase activity (GO:0060192) | 3.83488523 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 3.82275287 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 3.81155367 |
| 79 | glutamate metabolic process (GO:0006536) | 3.80381958 |
| 80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.79074937 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.79074937 |
| 82 | S-adenosylmethionine metabolic process (GO:0046500) | 3.74833932 |
| 83 | hormone catabolic process (GO:0042447) | 3.74702563 |
| 84 | cholesterol homeostasis (GO:0042632) | 3.74418519 |
| 85 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71279734 |
| 86 | heme transport (GO:0015886) | 3.70645360 |
| 87 | arginine catabolic process (GO:0006527) | 3.69167727 |
| 88 | short-chain fatty acid metabolic process (GO:0046459) | 3.68911999 |
| 89 | fibrinolysis (GO:0042730) | 3.68243071 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.67809584 |
| 91 | steroid catabolic process (GO:0006706) | 3.67062642 |
| 92 | arginine metabolic process (GO:0006525) | 3.66998685 |
| 93 | sterol homeostasis (GO:0055092) | 3.66662501 |
| 94 | very long-chain fatty acid metabolic process (GO:0000038) | 3.63707039 |
| 95 | plasma lipoprotein particle organization (GO:0071827) | 3.63308641 |
| 96 | cofactor catabolic process (GO:0051187) | 3.63033290 |
| 97 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.62924915 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.62742708 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.62742708 |
| 100 | aldehyde catabolic process (GO:0046185) | 3.62290937 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.62134270 |
| 102 | glycine metabolic process (GO:0006544) | 3.61142986 |
| 103 | intestinal cholesterol absorption (GO:0030299) | 3.60997821 |
| 104 | organic acid catabolic process (GO:0016054) | 3.59514275 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.59514275 |
| 106 | serine family amino acid metabolic process (GO:0009069) | 3.58528470 |
| 107 | protein-lipid complex assembly (GO:0065005) | 3.58375864 |
| 108 | complement activation (GO:0006956) | 3.56839356 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.56658020 |
| 110 | blood coagulation, intrinsic pathway (GO:0007597) | 3.55897273 |
| 111 | protein activation cascade (GO:0072376) | 3.55845513 |
| 112 | acetyl-CoA metabolic process (GO:0006084) | 3.55089157 |
| 113 | serine family amino acid biosynthetic process (GO:0009070) | 3.51043856 |
| 114 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.50588979 |
| 115 | complement activation, classical pathway (GO:0006958) | 3.50543822 |
| 116 | linoleic acid metabolic process (GO:0043651) | 3.50130432 |
| 117 | opioid receptor signaling pathway (GO:0038003) | 3.47768378 |
| 118 | negative regulation of blood coagulation (GO:0030195) | 3.46499718 |
| 119 | negative regulation of hemostasis (GO:1900047) | 3.46499718 |
| 120 | ketone body metabolic process (GO:1902224) | 3.46233973 |
| 121 | negative regulation of protein activation cascade (GO:2000258) | 3.44170394 |
| 122 | xenobiotic metabolic process (GO:0006805) | 3.39731260 |
| 123 | vitamin biosynthetic process (GO:0009110) | 3.39039873 |
| 124 | behavioral response to ethanol (GO:0048149) | 3.33089472 |
| 125 | regulation of plasminogen activation (GO:0010755) | 3.27624814 |
| 126 | negative regulation of coagulation (GO:0050819) | 3.18654260 |
| 127 | drug transmembrane transport (GO:0006855) | 3.17381456 |
| 128 | piRNA metabolic process (GO:0034587) | 3.16623419 |
| 129 | xenobiotic catabolic process (GO:0042178) | 3.15328240 |
| 130 | regulation of humoral immune response (GO:0002920) | 3.15140811 |
| 131 | negative regulation of complement activation (GO:0045916) | 3.08407912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.35450901 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.46531833 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.20385193 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.89367880 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.82064983 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63101456 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.31190732 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.64830231 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.39661049 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.60353247 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.44470876 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.28167077 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.20775741 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14607454 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.12338567 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2984926 |
| 17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75745658 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.74953317 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73190504 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70639412 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69198648 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66844030 |
| 23 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.64594706 |
| 24 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.64594706 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62644525 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60044211 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59557804 |
| 28 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.59127601 |
| 29 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.53137268 |
| 30 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.53137268 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52385340 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52308077 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50763439 |
| 34 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50310366 |
| 35 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.50310366 |
| 36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.49067766 |
| 37 | TCF4_23295773_ChIP-Seq_U87_Human | 1.44405442 |
| 38 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44166064 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.41182104 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37766234 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36306683 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35390020 |
| 43 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33462454 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33443411 |
| 45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31221299 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30538919 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28762333 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28114312 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27741164 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27438087 |
| 51 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25407835 |
| 52 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.24207613 |
| 53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23270435 |
| 54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22503846 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21541678 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20696261 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19575058 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15953867 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15909376 |
| 60 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13299099 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12699743 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11389860 |
| 63 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11345016 |
| 64 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11058208 |
| 65 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09446947 |
| 66 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09400504 |
| 67 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08910875 |
| 68 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08558934 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07664437 |
| 70 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06985973 |
| 71 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06960672 |
| 72 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06960672 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05836863 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04965282 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04613613 |
| 76 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04287958 |
| 77 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03442316 |
| 78 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.02692087 |
| 79 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02482342 |
| 80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01747900 |
| 81 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.01612864 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01580305 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00942255 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00252770 |
| 85 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99782854 |
| 86 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98754943 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98130239 |
| 88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97797614 |
| 89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97778809 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97468460 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.96230543 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96067115 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96067115 |
| 94 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.91372022 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90539485 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90412601 |
| 97 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90258343 |
| 98 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87328568 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82879781 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82870890 |
| 101 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78654482 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78452003 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78174038 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76779246 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75871833 |
| 106 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74682585 |
| 107 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.72654079 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72061225 |
| 109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71323703 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70488837 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69497581 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.68718182 |
| 113 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.68259330 |
| 114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.67797623 |
| 115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67438460 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67252265 |
| 117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.66510920 |
| 118 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66104154 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.65990992 |
| 120 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65722395 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.65120128 |
| 122 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.64782338 |
| 123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64430297 |
| 124 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.64088159 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63672104 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62868734 |
| 127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.62049827 |
| 128 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.61776207 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61507676 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.61375124 |
| 131 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.61321266 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.61306943 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.61048958 |
| 134 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60724693 |
| 135 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.59715569 |
| 136 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.59547018 |
| 137 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.59265767 |
| 138 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58447048 |
| 139 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58247176 |
| 140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57580725 |
| 141 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55296860 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.54294340 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.53710761 |
| 144 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.53219920 |
| 145 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.52348648 |
| 146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51826123 |
| 147 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.51465921 |
| 148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51413615 |
| 149 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.49883521 |
| 150 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49670837 |
| 151 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.49591906 |
| 152 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.48803546 |
| 153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48800815 |
| 154 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.48703322 |
| 155 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.48628579 |
| 156 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.48352196 |
| 157 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.47544201 |
| 158 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.47507335 |
| 159 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.47391418 |
| 160 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.47148456 |
| 161 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46590903 |
| 162 | KDM2B_26808549_Chip-Seq_REH_Human | 0.46068877 |
| 163 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.45775715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.92136634 |
| 2 | MP0005360_urolithiasis | 7.34219749 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.18849932 |
| 4 | MP0005365_abnormal_bile_salt | 5.87608476 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.96009432 |
| 6 | MP0003252_abnormal_bile_duct | 3.84985446 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.76899967 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57958809 |
| 9 | MP0009840_abnormal_foam_cell | 3.33194435 |
| 10 | MP0005083_abnormal_biliary_tract | 2.85484324 |
| 11 | MP0005332_abnormal_amino_acid | 2.72968206 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.71920184 |
| 13 | MP0003195_calcinosis | 2.65200496 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.44546971 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.27745083 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.17864523 |
| 17 | MP0000609_abnormal_liver_physiology | 2.04134142 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.90615089 |
| 19 | MP0009697_abnormal_copulation | 1.73344353 |
| 20 | MP0001764_abnormal_homeostasis | 1.68960023 |
| 21 | MP0003868_abnormal_feces_composition | 1.67775727 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.66411266 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.65527196 |
| 24 | MP0005451_abnormal_body_composition | 1.63771911 |
| 25 | MP0003011_delayed_dark_adaptation | 1.54132732 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53532085 |
| 27 | MP0001968_abnormal_touch/_nociception | 1.41902286 |
| 28 | MP0002254_reproductive_system_inflammat | 1.41179837 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.40300129 |
| 30 | MP0003690_abnormal_glial_cell | 1.37984778 |
| 31 | MP0005670_abnormal_white_adipose | 1.37780993 |
| 32 | MP0003186_abnormal_redox_activity | 1.32211135 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.25634187 |
| 34 | MP0001501_abnormal_sleep_pattern | 1.23259795 |
| 35 | MP0005647_abnormal_sex_gland | 1.22532439 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.21666168 |
| 37 | MP0009764_decreased_sensitivity_to | 1.17595172 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.14634623 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.13957575 |
| 40 | MP0003879_abnormal_hair_cell | 1.09964389 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.08585036 |
| 42 | MP0003136_yellow_coat_color | 1.07627605 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.06699766 |
| 44 | MP0000604_amyloidosis | 1.05430416 |
| 45 | MP0009763_increased_sensitivity_to | 1.03712059 |
| 46 | MP0004043_abnormal_pH_regulation | 1.02063673 |
| 47 | MP0000598_abnormal_liver_morphology | 0.99090604 |
| 48 | MP0009053_abnormal_anal_canal | 0.98270243 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 0.94788795 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 0.93303092 |
| 51 | MP0008469_abnormal_protein_level | 0.91117276 |
| 52 | MP0003724_increased_susceptibility_to | 0.90908014 |
| 53 | MP0002272_abnormal_nervous_system | 0.89185651 |
| 54 | MP0002971_abnormal_brown_adipose | 0.88418241 |
| 55 | MP0003880_abnormal_central_pattern | 0.86518198 |
| 56 | MP0009745_abnormal_behavioral_response | 0.84956603 |
| 57 | MP0009642_abnormal_blood_homeostasis | 0.84208754 |
| 58 | MP0005334_abnormal_fat_pad | 0.83954143 |
| 59 | MP0004142_abnormal_muscle_tone | 0.83783152 |
| 60 | MP0009765_abnormal_xenobiotic_induced | 0.82424047 |
| 61 | MP0010386_abnormal_urinary_bladder | 0.82209438 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 0.81729975 |
| 63 | MP0010368_abnormal_lymphatic_system | 0.80931183 |
| 64 | MP0004130_abnormal_muscle_cell | 0.80478181 |
| 65 | MP0004381_abnormal_hair_follicle | 0.80096668 |
| 66 | MP0001664_abnormal_digestion | 0.78337833 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.77578561 |
| 68 | MP0005408_hypopigmentation | 0.77165665 |
| 69 | MP0005187_abnormal_penis_morphology | 0.76479477 |
| 70 | MP0005535_abnormal_body_temperature | 0.75941313 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 0.72166318 |
| 72 | MP0001485_abnormal_pinna_reflex | 0.70352441 |
| 73 | MP0001661_extended_life_span | 0.68687062 |
| 74 | MP0004147_increased_porphyrin_level | 0.68363443 |
| 75 | MP0002638_abnormal_pupillary_reflex | 0.67575567 |
| 76 | MP0008775_abnormal_heart_ventricle | 0.66177962 |
| 77 | MP0006082_CNS_inflammation | 0.66031740 |
| 78 | MP0005448_abnormal_energy_balance | 0.65288830 |
| 79 | MP0002168_other_aberrant_phenotype | 0.64482190 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.64009023 |
| 81 | MP0003646_muscle_fatigue | 0.63966115 |
| 82 | MP0000427_abnormal_hair_cycle | 0.63633596 |
| 83 | MP0003959_abnormal_lean_body | 0.63346233 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.63227625 |
| 85 | MP0002249_abnormal_larynx_morphology | 0.62204325 |
| 86 | MP0001984_abnormal_olfaction | 0.61227610 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.61010061 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.60772516 |
| 89 | MP0005503_abnormal_tendon_morphology | 0.60770259 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.60436620 |
| 91 | MP0003075_altered_response_to | 0.60423961 |
| 92 | MP0001324_abnormal_eye_pigmentation | 0.60165802 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.59669845 |
| 94 | MP0003329_amyloid_beta_deposits | 0.59489850 |
| 95 | MP0005195_abnormal_posterior_eye | 0.59382252 |
| 96 | MP0001486_abnormal_startle_reflex | 0.58922326 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.58656525 |
| 98 | MP0006292_abnormal_olfactory_placode | 0.57692440 |
| 99 | MP0002132_abnormal_respiratory_system | 0.57321179 |
| 100 | MP0000566_synostosis | 0.53135473 |
| 101 | MP0005266_abnormal_metabolism | 0.51789413 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.51597070 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.51427135 |
| 104 | MP0008877_abnormal_DNA_methylation | 0.51048429 |
| 105 | MP0000538_abnormal_urinary_bladder | 0.50909107 |
| 106 | MP0001756_abnormal_urination | 0.50887646 |
| 107 | MP0008789_abnormal_olfactory_epithelium | 0.50799388 |
| 108 | MP0009115_abnormal_fat_cell | 0.50570906 |
| 109 | MP0003941_abnormal_skin_development | 0.50429528 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.49583571 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.49425052 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.48020683 |
| 113 | MP0006072_abnormal_retinal_apoptosis | 0.47292492 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.47216880 |
| 115 | MP0009046_muscle_twitch | 0.46582666 |
| 116 | MP0003718_maternal_effect | 0.46573951 |
| 117 | MP0003567_abnormal_fetal_cardiomyocyte | 0.46343818 |
| 118 | MP0002557_abnormal_social/conspecific_i | 0.46086843 |
| 119 | MP0005395_other_phenotype | 0.45803191 |
| 120 | MP0009384_cardiac_valve_regurgitation | 0.44667378 |
| 121 | MP0002837_dystrophic_cardiac_calcinosis | 0.44632654 |
| 122 | MP0001853_heart_inflammation | 0.44548362 |
| 123 | MP0008872_abnormal_physiological_respon | 0.43909359 |
| 124 | MP0005166_decreased_susceptibility_to | 0.43695066 |
| 125 | MP0008874_decreased_physiological_sensi | 0.43507251 |
| 126 | MP0004883_abnormal_blood_vessel | 0.43231968 |
| 127 | MP0005164_abnormal_response_to | 0.43064343 |
| 128 | MP0002928_abnormal_bile_duct | 0.42336964 |
| 129 | MP0003953_abnormal_hormone_level | 0.40924358 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.40786336 |
| 131 | MP0000249_abnormal_blood_vessel | 0.40187033 |
| 132 | MP0000579_abnormal_nail_morphology | 0.38616025 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.37232798 |
| 134 | MP0003436_decreased_susceptibility_to | 0.36775146 |
| 135 | MP0002090_abnormal_vision | 0.36529240 |
| 136 | MP0008873_increased_physiological_sensi | 0.36487057 |
| 137 | MP0001881_abnormal_mammary_gland | 0.36132763 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.35460836 |
| 139 | MP0002796_impaired_skin_barrier | 0.35172998 |
| 140 | MP0000920_abnormal_myelination | 0.32241248 |
| 141 | MP0002822_catalepsy | 0.31529442 |
| 142 | MP0002419_abnormal_innate_immunity | 0.30061664 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.29826025 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.29642426 |
| 145 | MP0003633_abnormal_nervous_system | 0.29285873 |
| 146 | MP0002060_abnormal_skin_morphology | 0.29052481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.10380329 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.88551805 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.74964355 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.34369510 |
| 5 | Xanthomatosis (HP:0000991) | 6.13635165 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.12457670 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.08714470 |
| 8 | Complement deficiency (HP:0004431) | 5.50912090 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.44455480 |
| 10 | Thyroid-stimulating hormone excess (HP:0002925) | 4.83376629 |
| 11 | Joint hemorrhage (HP:0005261) | 4.79938439 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.68449900 |
| 13 | Epidermoid cyst (HP:0200040) | 4.43639796 |
| 14 | Hyperammonemia (HP:0001987) | 4.41366709 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36193339 |
| 16 | Hyperglycinemia (HP:0002154) | 4.32538391 |
| 17 | Hyperglycinuria (HP:0003108) | 4.20209686 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.18336792 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17513475 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.15020036 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.15020036 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.14595677 |
| 23 | Fat malabsorption (HP:0002630) | 4.14482975 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09191074 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 4.04627696 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.03100640 |
| 27 | Ketosis (HP:0001946) | 4.00869688 |
| 28 | Abnormality of complement system (HP:0005339) | 3.99017367 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.91742998 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.75407516 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.63712606 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.57758033 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45178958 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35335131 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34091194 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.33534140 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.12190749 |
| 38 | Steatorrhea (HP:0002570) | 3.11407281 |
| 39 | Large for gestational age (HP:0001520) | 3.08832625 |
| 40 | Osteomalacia (HP:0002749) | 3.04642143 |
| 41 | Glomerulonephritis (HP:0000099) | 3.03732138 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.99220596 |
| 43 | Myocardial infarction (HP:0001658) | 2.97742556 |
| 44 | Delayed CNS myelination (HP:0002188) | 2.93808675 |
| 45 | Fair hair (HP:0002286) | 2.92614333 |
| 46 | Ketoacidosis (HP:0001993) | 2.87147161 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.86755688 |
| 48 | Metabolic acidosis (HP:0001942) | 2.73652400 |
| 49 | Acanthocytosis (HP:0001927) | 2.72266566 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.71603885 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71603885 |
| 52 | Vascular calcification (HP:0004934) | 2.71258758 |
| 53 | Skin nodule (HP:0200036) | 2.71150642 |
| 54 | Amyloidosis (HP:0011034) | 2.68378487 |
| 55 | Intestinal atresia (HP:0011100) | 2.66161579 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.65018056 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.61525297 |
| 58 | Spontaneous abortion (HP:0005268) | 2.58523148 |
| 59 | Hyperventilation (HP:0002883) | 2.58501634 |
| 60 | Lethargy (HP:0001254) | 2.54300577 |
| 61 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.53007509 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.51254515 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.46934592 |
| 64 | Type II lissencephaly (HP:0007260) | 2.46641523 |
| 65 | Hyperphosphaturia (HP:0003109) | 2.40682505 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.39305133 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29072415 |
| 68 | Volvulus (HP:0002580) | 2.28578452 |
| 69 | Cerebral edema (HP:0002181) | 2.27278755 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.24604550 |
| 71 | Hypophosphatemic rickets (HP:0004912) | 2.24371482 |
| 72 | Irritability (HP:0000737) | 2.24215266 |
| 73 | Pancreatitis (HP:0001733) | 2.24007130 |
| 74 | Proximal tubulopathy (HP:0000114) | 2.23866636 |
| 75 | Gaze-evoked nystagmus (HP:0000640) | 2.22872547 |
| 76 | Chronic hepatic failure (HP:0100626) | 2.20732999 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 2.19783296 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.19411832 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.19411832 |
| 80 | Renal cortical cysts (HP:0000803) | 2.19154073 |
| 81 | Esophageal varix (HP:0002040) | 2.18746009 |
| 82 | Tubular atrophy (HP:0000092) | 2.16709099 |
| 83 | Gingival bleeding (HP:0000225) | 2.16469215 |
| 84 | Generalized hypopigmentation of hair (HP:0011358) | 2.15512412 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.15190432 |
| 86 | Malnutrition (HP:0004395) | 2.14264860 |
| 87 | Pancreatic cysts (HP:0001737) | 2.12884388 |
| 88 | Mitral stenosis (HP:0001718) | 2.12438404 |
| 89 | Enlarged kidneys (HP:0000105) | 2.11625702 |
| 90 | Potter facies (HP:0002009) | 2.09505971 |
| 91 | Facial shape deformation (HP:0011334) | 2.09505971 |
| 92 | Menorrhagia (HP:0000132) | 2.08720883 |
| 93 | Cholelithiasis (HP:0001081) | 2.08467687 |
| 94 | Opisthotonus (HP:0002179) | 2.08352775 |
| 95 | Brushfield spots (HP:0001088) | 2.07884758 |
| 96 | Abnormal urine phosphate concentration (HP:0012599) | 2.06695345 |
| 97 | Nephritis (HP:0000123) | 2.05620621 |
| 98 | Rickets (HP:0002748) | 2.05329897 |
| 99 | Hypothermia (HP:0002045) | 2.05299562 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.03171189 |
| 101 | Vomiting (HP:0002013) | 2.02151261 |
| 102 | Abnormality of vitamin metabolism (HP:0100508) | 1.97645211 |
| 103 | Hemorrhage of the eye (HP:0011885) | 1.97118000 |
| 104 | Cholecystitis (HP:0001082) | 1.96541930 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 1.96541930 |
| 106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95856558 |
| 107 | Agitation (HP:0000713) | 1.93971628 |
| 108 | Spastic diplegia (HP:0001264) | 1.89524732 |
| 109 | Hypertriglyceridemia (HP:0002155) | 1.88754501 |
| 110 | Poikilocytosis (HP:0004447) | 1.88097603 |
| 111 | Neonatal onset (HP:0003623) | 1.87491445 |
| 112 | Thrombophlebitis (HP:0004418) | 1.87464620 |
| 113 | Attenuation of retinal blood vessels (HP:0007843) | 1.87432713 |
| 114 | Pancreatic fibrosis (HP:0100732) | 1.87383233 |
| 115 | Elevated hepatic transaminases (HP:0002910) | 1.87249053 |
| 116 | Congenital stationary night blindness (HP:0007642) | 1.87155945 |
| 117 | Glycosuria (HP:0003076) | 1.86662021 |
| 118 | Abnormality of urine glucose concentration (HP:0011016) | 1.86662021 |
| 119 | Gout (HP:0001997) | 1.86317097 |
| 120 | Abnormal biliary tract physiology (HP:0012439) | 1.85038967 |
| 121 | Bile duct proliferation (HP:0001408) | 1.85038967 |
| 122 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84528130 |
| 123 | Mesangial abnormality (HP:0001966) | 1.82230957 |
| 124 | Alkalosis (HP:0001948) | 1.81823650 |
| 125 | Pigmentary retinal degeneration (HP:0001146) | 1.81304076 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 1.80984086 |
| 127 | Confusion (HP:0001289) | 1.80401112 |
| 128 | Molar tooth sign on MRI (HP:0002419) | 1.77912030 |
| 129 | Abnormality of midbrain morphology (HP:0002418) | 1.77912030 |
| 130 | Methylmalonic aciduria (HP:0012120) | 1.77132652 |
| 131 | Medial flaring of the eyebrow (HP:0010747) | 1.76249857 |
| 132 | Arthropathy (HP:0003040) | 1.75592493 |
| 133 | Abnormality of the vitreous humor (HP:0004327) | 1.75162801 |
| 134 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.75018518 |
| 135 | Abnormality of alanine metabolism (HP:0010916) | 1.75018518 |
| 136 | Hyperalaninemia (HP:0003348) | 1.75018518 |
| 137 | Poor head control (HP:0002421) | 1.70621953 |
| 138 | Abnormality of the aortic arch (HP:0012303) | 1.69754267 |
| 139 | Abnormality of vitamin B metabolism (HP:0004340) | 1.68873326 |
| 140 | Congenital sensorineural hearing impairment (HP:0008527) | 1.67042005 |
| 141 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.66671766 |
| 142 | Oligodontia (HP:0000677) | 1.65399283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.94657441 |
| 2 | SIK1 | 4.00209759 |
| 3 | FGFR4 | 3.77355751 |
| 4 | INSRR | 3.60390344 |
| 5 | ERN1 | 3.38763191 |
| 6 | ACVR1B | 3.20678094 |
| 7 | TAOK3 | 2.55326269 |
| 8 | MST1R | 2.36609634 |
| 9 | ERBB4 | 2.22382604 |
| 10 | IRAK3 | 2.19389010 |
| 11 | WNK3 | 2.09426411 |
| 12 | MAP4K2 | 2.02268240 |
| 13 | TGFBR2 | 2.00531211 |
| 14 | PNCK | 1.96385706 |
| 15 | MAPK15 | 1.93095832 |
| 16 | PRKCG | 1.92348966 |
| 17 | ADRBK1 | 1.88310301 |
| 18 | FRK | 1.84584176 |
| 19 | ZAK | 1.84426132 |
| 20 | PIK3CG | 1.79182078 |
| 21 | TIE1 | 1.78195501 |
| 22 | EPHB1 | 1.77394901 |
| 23 | CAMK1D | 1.70132779 |
| 24 | TYK2 | 1.64918614 |
| 25 | FGFR2 | 1.62302875 |
| 26 | MAP3K14 | 1.61780247 |
| 27 | TNIK | 1.58589709 |
| 28 | WNK4 | 1.50131019 |
| 29 | MAPK11 | 1.49176919 |
| 30 | GRK1 | 1.44621981 |
| 31 | PRKAA2 | 1.41848326 |
| 32 | KDR | 1.34088747 |
| 33 | MAP2K4 | 1.34040595 |
| 34 | TGFBR1 | 1.30006790 |
| 35 | MAP3K4 | 1.26238194 |
| 36 | EPHA3 | 1.18612117 |
| 37 | MAPK12 | 1.17975365 |
| 38 | LATS1 | 1.16527551 |
| 39 | CAMK1G | 1.15632044 |
| 40 | PKN1 | 1.14587260 |
| 41 | NTRK3 | 1.12951023 |
| 42 | JAK1 | 1.12538634 |
| 43 | NEK9 | 1.10922403 |
| 44 | PLK2 | 1.07266497 |
| 45 | PBK | 1.05261525 |
| 46 | ABL2 | 1.05051270 |
| 47 | MET | 1.03572846 |
| 48 | DAPK2 | 0.99408646 |
| 49 | JAK2 | 0.97380761 |
| 50 | MAPK7 | 0.97019214 |
| 51 | MAPK4 | 0.96208948 |
| 52 | PTK6 | 0.94658165 |
| 53 | PINK1 | 0.92350182 |
| 54 | PRKCI | 0.90653615 |
| 55 | GSK3A | 0.87491092 |
| 56 | ERBB2 | 0.87488045 |
| 57 | EIF2AK3 | 0.86936398 |
| 58 | BRSK2 | 0.86725697 |
| 59 | IRAK1 | 0.86615054 |
| 60 | SGK223 | 0.86535052 |
| 61 | SGK494 | 0.86535052 |
| 62 | MAP3K7 | 0.86225992 |
| 63 | MAP2K2 | 0.84291449 |
| 64 | GRK7 | 0.83925029 |
| 65 | TLK1 | 0.82935707 |
| 66 | PRKCZ | 0.81073207 |
| 67 | CAMKK2 | 0.79481191 |
| 68 | MAPK13 | 0.78828443 |
| 69 | GRK6 | 0.78640169 |
| 70 | CAMK2A | 0.77106584 |
| 71 | CSK | 0.76861349 |
| 72 | FLT3 | 0.76525545 |
| 73 | CSF1R | 0.75701737 |
| 74 | PRKACG | 0.75427781 |
| 75 | IKBKE | 0.75047007 |
| 76 | TBK1 | 0.74214752 |
| 77 | CAMK2G | 0.73827445 |
| 78 | PRKCQ | 0.73361814 |
| 79 | NTRK2 | 0.72048716 |
| 80 | NLK | 0.71435541 |
| 81 | IRAK2 | 0.69661607 |
| 82 | IRAK4 | 0.66326261 |
| 83 | EPHA4 | 0.65740999 |
| 84 | IGF1R | 0.65059529 |
| 85 | MKNK2 | 0.64293949 |
| 86 | SGK1 | 0.63401952 |
| 87 | FGFR3 | 0.63133384 |
| 88 | PAK3 | 0.61825998 |
| 89 | PIK3CA | 0.61796803 |
| 90 | TEC | 0.60647104 |
| 91 | ADRBK2 | 0.58469339 |
| 92 | PRKAA1 | 0.58284201 |
| 93 | NUAK1 | 0.58026734 |
| 94 | STK16 | 0.57851566 |
| 95 | SGK2 | 0.57827362 |
| 96 | LMTK2 | 0.56206927 |
| 97 | MAP2K6 | 0.56088578 |
| 98 | BLK | 0.54856456 |
| 99 | BMPR2 | 0.54047974 |
| 100 | MAP3K9 | 0.53504340 |
| 101 | CSNK1A1 | 0.53110278 |
| 102 | SGK3 | 0.52385985 |
| 103 | PDPK1 | 0.51728170 |
| 104 | CAMK1 | 0.51124851 |
| 105 | STK3 | 0.51095022 |
| 106 | MUSK | 0.50595003 |
| 107 | PDK2 | 0.50161327 |
| 108 | BMPR1B | 0.50090369 |
| 109 | STK38L | 0.49704657 |
| 110 | DYRK1A | 0.49644852 |
| 111 | STK39 | 0.48314377 |
| 112 | VRK1 | 0.47927878 |
| 113 | NEK2 | 0.47744258 |
| 114 | CSNK1E | 0.46233994 |
| 115 | TNK2 | 0.45553252 |
| 116 | MAP3K3 | 0.45516644 |
| 117 | PRKG2 | 0.45307585 |
| 118 | CDK6 | 0.45252937 |
| 119 | PRKCB | 0.45014016 |
| 120 | EIF2AK2 | 0.44895636 |
| 121 | CDK3 | 0.43042355 |
| 122 | DYRK3 | 0.42324503 |
| 123 | MARK1 | 0.41209699 |
| 124 | CSNK1G1 | 0.40638643 |
| 125 | CSNK1D | 0.40337221 |
| 126 | BCR | 0.40022307 |
| 127 | PRKCA | 0.39457714 |
| 128 | GRK5 | 0.39222200 |
| 129 | PRKD1 | 0.39210402 |
| 130 | AKT3 | 0.38911271 |
| 131 | MAP2K3 | 0.38274320 |
| 132 | ABL1 | 0.38255611 |
| 133 | DYRK2 | 0.38054705 |
| 134 | IKBKB | 0.37975690 |
| 135 | PHKG1 | 0.37957026 |
| 136 | PHKG2 | 0.37957026 |
| 137 | ERBB3 | 0.37871351 |
| 138 | PRKACB | 0.37206237 |
| 139 | MAP2K7 | 0.36945261 |
| 140 | CASK | 0.36553986 |
| 141 | EPHB2 | 0.35211288 |
| 142 | CSNK1G2 | 0.35120208 |
| 143 | CSNK1G3 | 0.34401237 |
| 144 | PRKACA | 0.33623042 |
| 145 | TYRO3 | 0.33443732 |
| 146 | MAPKAPK5 | 0.33337668 |
| 147 | RPS6KA3 | 0.33075549 |
| 148 | CHUK | 0.32619790 |
| 149 | OXSR1 | 0.32448564 |
| 150 | PRKCE | 0.32338912 |
| 151 | CAMK4 | 0.31920844 |
| 152 | CAMK2D | 0.31752122 |
| 153 | PRKG1 | 0.31536551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.20110756 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56795372 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10337389 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.89142919 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74447047 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.65292611 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63942113 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59870433 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52214680 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43505324 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.35953469 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35075439 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.28526415 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20289180 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.13429306 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12832729 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11544095 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04123464 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.03479549 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01293229 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00518140 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99784781 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.98330051 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88785025 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84512517 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82553467 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81543207 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.81445845 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.75443561 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72508265 |
| 31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.67005388 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58809312 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55141655 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50241991 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47208818 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.45000199 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39238309 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39055930 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36480485 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.35687535 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33167269 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30470104 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25260736 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24956698 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22037037 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.20754540 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16971419 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02708975 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02093899 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00400630 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99533923 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98126191 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96753621 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96655011 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92187416 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89282317 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84645481 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83267992 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80831138 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77579229 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74363446 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.70136729 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55120358 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54232257 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51357029 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49822901 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49467251 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.48512435 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48486724 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47185408 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45289917 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43590769 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37451130 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.32301191 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31020415 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28395457 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28088260 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26548560 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.26218286 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21655041 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21080679 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17876753 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.17728363 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.15542604 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15383709 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.14480382 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12607114 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.11488442 |
| 89 | Nicotine addiction_Homo sapiens_hsa05033 | 0.10902447 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.08878240 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.08733480 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05497842 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.05450014 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.05411761 |
| 95 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.04722537 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.04012899 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02621422 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.02526398 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02451464 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.02350944 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1585064 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1452948 |
| 103 | Lysosome_Homo sapiens_hsa04142 | -0.1440153 |
| 104 | Malaria_Homo sapiens_hsa05144 | -0.1368221 |
| 105 | Pertussis_Homo sapiens_hsa05133 | -0.1361319 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | -0.1350428 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1336616 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1329068 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1319100 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1197827 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0999953 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0558560 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0328712 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0292087 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0224906 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0009872 |

